ABOUT ALEX TRIBO
ALEX TRIBO
RESEARCH & DEVELOPMENT ADVISOR
ABOUT ME
Alex Tribo is a scientist, patient advocate, culture-builder, and multipotentialite with nine years of experience spanning wet lab, academic, industry, state and federal government settings, where she has specialized in psychiatric research (including launching some of the first-of-their-kind psychedelic trials) and its meaningful translation and implementation to the public. She takes pride in bringing a rare bench-to-clinic-to-policy perspective to her work.
Alex is currently pursuing a Master of Public Health at the Johns Hopkins Bloomberg School of Public Health with a focus on clinical trials, psychedelic bioethics, pharmacoepidemiology and drug safety, U.S. regulatory policy, and mental health policy. She maintains close ties to the Johns Hopkins Center for Psychedelic and Consciousness Research where she began her clinical research training, and continues to build rich relationships with researchers, activists, clinicians, and patients in the psychedelic and psychiatric space. Above all, Alex cares about people: who benefits from the research, who gets access to care, how that care is delivered, and whether the systems behind these efforts are equitable and ethical.
BEYOND THE WORK
Alex's personal interests include ethnobotany, philosophy, poetry, baking, and late, sprawling evening walks.
She strongly abides by the Latin phrase solvitur ambulando — "it is solved by walking" — when thinking through life's mysteries.
MY BACKGROUND
-
Clinical Trial Operations & Infrastructure
-
Psychedelic Science, Policy & Bioethics
-
Psychiatric Pharmacovigilance & Drug Safety
-
U.S. Regulatory Science & Policy
-
Implementation Science & Real-World Evidence (RWE)
-
Science Writing & Communication
WHAT I'M WORKING ON:
Alex is currently spearheading a first-of-its-kind psychedelic clinical trial for active duty military service members at Walter Reed National Military Medical Center, while collaborating with the Psychedelic Center for Public Health to evaluate psychedelic-assisted interventions against USPSTF preventive service criteria for tobacco, alcohol, and opioid use disorders. Alongside her clinical and academic work, she is building a clinical trial operations consulting practice and completing her MPH at Johns Hopkins. She holds a special interest in bringing psychedelic clinical trials—and eventually care—to Appalachia, where the need for well-resourced and innovative mental health treatment is significant. She welcomes collaborations across research efforts, policy, advocacy, science writing, and program development.